Interventions for idiopathic intracranial hypertension

Area of Science:

• Ophthalmology and Neurology
• Clinical Trial Analysis
• Evidence-Based Medicine

Background:

• Idiopathic intracranial hypertension (IIH) affects predominantly obese young women, posing risks of vision loss and severe headaches.
• Current management strategies include weight loss, diuretics, and surgical interventions for refractory cases.

Purpose of the Study:

• To evaluate the effectiveness of interventions for idiopathic intracranial hypertension (IIH).
• To synthesize findings from randomized controlled trials (RCTs) assessing IIH treatments.

Main Methods:

• Conducted a systematic search of multiple electronic databases for RCTs on IIH interventions.
• Included RCTs comparing any intervention against placebo or another treatment for diagnosed IIH patients.
• Two independent reviewers assessed trial eligibility and extracted data.

Main Results:

• Two completed RCTs (211 participants) compared acetazolamide with placebo, alongside weight loss interventions.
• Acetazolamide showed potential modest benefits in reducing papilledema and possibly CSF pressure, but visual acuity changes were similar to placebo.
• Evidence quality was low due to imprecision and risk of bias; side effects like gastrointestinal issues and fatigue were noted with acetazolamide.

Conclusions:

• The current evidence from two RCTs is insufficient to recommend or reject acetazolamide for IIH treatment.
• Further high-quality randomized controlled trials are necessary to determine the efficacy and safety of acetazolamide in IIH patients.
• The study highlights the need for more robust research to guide IIH management.